(Q80809181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Kazuhiro Imai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Seizo Yamamoto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yorito Anamizu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Toshiyuki Horiuchi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

25 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Metabolism

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

333-336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00774-007-0771-y

3 January 2020

exact match

0 references

cites work

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

1 reference

12 December 2020

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

1 reference

12 December 2020

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

1 reference

12 December 2020

Effects of differences in mineralization on the mechanical properties of bone

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis

1 reference

12 December 2020

Unsuspected sacral fractures: detection by radionuclide bone scanning

1 reference

12 December 2020

Changes in biochemical markers of bone in patients with insufficiency fractures.

1 reference

12 December 2020

Long-term safety of bisphosphonates

1 reference

12 December 2020

Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry

1 reference

12 December 2020

Pubic and sacral insufficiency fractures: clinical course and radiologic findings

1 reference

12 December 2020

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

1 reference

12 December 2020

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females

1 reference

12 December 2020

Detection of osteoporotic sacral fractures with radionuclides

1 reference

12 December 2020

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Fractures after long-term alendronate therapy

1 reference

12 December 2020

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

1 reference

12 December 2020

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

12 December 2020

10.1007/S00774-007-0771-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17704999%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference